National Bank of Canada’s Avanos Medical AVNS Stock Holding History

National Bank of Canada’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$251	Hold	18	–	–	﹤0.01%	2783
2025 Q4	$202	Hold	18	–	–	﹤0.01%	2750
2025 Q3	$204	Buy	+18	New	+$211	﹤0.01%	2741
2024 Q4	–	Sell	-7	Closed	-$168	–	2947
2024 Q3	$168	Sell	7 -19	-73%	-$434	﹤0.01%	2537
2024 Q2	$512	Hold	26	–	–	﹤0.01%	2562
2024 Q1	$509	Sell	26 -12	-32%	-$232	﹤0.01%	2598
2023 Q4	$861	Buy	38 +12	+46%	+$248	﹤0.01%	2552
2023 Q3	$525	Hold	26	–	–	﹤0.01%	2651
2023 Q2	$664	Hold	26	–	–	﹤0.01%	2592
2023 Q1	$773	Sell	26 -6	-19%	-$174	﹤0.01%	2557
2022 Q4	$866	Buy	32 +2	+7%	+$49	﹤0.01%	2596
2022 Q3	$1K	Sell	30 -320	-91%	-$8.36K	﹤0.01%	2572
2022 Q2	$10K	Buy	350 +295	+536%	+$8.48K	﹤0.01%	2257
2022 Q1	$2K	Hold	55	–	–	﹤0.01%	2690
2021 Q4	$2K	Buy	+55	New	+$1.78K	﹤0.01%	2665

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

National Bank of Canada's AVNS Position: Q1 2026 in Review

National Bank of Canada held its Avanos Medical (AVNS) position steady in Q1 2026 at 18 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

National Bank of Canada first reported a position in AVNS in Q4 2021 and has held it in 15 quarters since. The position peaked at $10K in Q2 2022. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

National Bank of Canada held 18 shares of Avanos Medical worth $251 as of Q1 2026.
National Bank of Canada left its Avanos Medical share count unchanged in Q1 2026.
Avanos Medical made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2783 holding.
National Bank of Canada first reported a position in Avanos Medical in Q4 2021 and has held it in 15 quarters since.
National Bank of Canada's Avanos Medical position peaked at $10K in Q2 2022.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.